Terns Pharmaceuticals, Inc. (TERN)
52.65
-0.04
(-0.08%)
USD |
NASDAQ |
Apr 17, 16:00
52.62
-0.03
(-0.06%)
Pre-Market: 20:00
Terns Pharmaceuticals Free Cash Flow : -82.18M for Dec. 31, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Merck & Co., Inc. | 12.36B |
| Corcept Therapeutics, Inc. | 141.78M |
| Cogent Biosciences, Inc. | -266.00M |
| BioMarin Pharmaceutical, Inc. | 717.02M |
| ADMA Biologics, Inc. | 27.50M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -19.08M |
| Cash from Investing (Quarterly) | -350.00M |
| Cash from Financing (Quarterly) | 743.12M |
| Free Cash Flow Per Share (Quarterly) | -0.1939 |
| Free Cash Flow to Equity (Quarterly) | -18.97M |
| Free Cash Flow to Firm (Quarterly) | -19.08M |
| Free Cash Flow Yield | -1.67% |